Searchable abstracts of presentations at key conferences in endocrinology

ea0086s5.2 | New approaches to diagnosing and treating thyroid cancer | SFEBES2022

Are we overtreating low-risk thyroid cancer?

Haymart Megan

Patients with low-risk thyroid cancer are at risk for overtreatment. Autopsy studies and survival statistics suggest that many patients with thyroid cancer have indolent disease that is unlikely to lead to death. Prior studies have found similar long-term outcomes with less intensive management. Yet, there remains marked variation in care, with some patients at risk for overtreatment. Data from large cancer registries, as well as patient report, provide evidence that overtreat...